Cost-effectiveness analysis of two management strategies for dyspepsia (Q57811075)

https://api.crossref.org/works/10.1017%2FS0266462307070420

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Dyspepsia management in primary care: a decision analysis of competing strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Cost implications of routine mammography screening of women 50-69 years in the county of Funen, Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Gastroenterology in the Trent Region in 1992 and a review of changes since 1975

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Trends in diagnostic testing following a national guideline for evaluation of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Economic costs of functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Cost-effectiveness of alternative approaches in the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Management in general practice of patients with persistent dyspepsia. A decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Has education about Helicobacter pylori infection been effective? Worldwide survey of primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Systemic review: the prevalence and clinical course of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Trends in the utilization of diagnostic upper GI endoscopy in New South Wales, Australia, 1988 to 1998

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

General practitioners' approach to dyspepsia. Survey of consultation frequencies, treatment, and investigations

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Indirect cost in economic evaluation: the opportunity cost of unpaid inputs

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Estimating the cost of lost productivity in dyspepsia

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

The management of dyspepsia: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Patient, physician, and payer perceptions and misperceptions of willingness to pay for diagnostic certainty

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Initial management strategies for dyspepsia

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021

Alternative management strategies for patients with suspected peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1017%2FS0266462307070420

7 January 2021